Medical News

RSS

Improvement in mumps vaccine administration needed to prevent future outbreaks

Although immunity to mumps is high in the United States, mumps vaccine coverage must be maintained and improved to prevent future outbreaks, according to a new study, now available online (http://www.journals.uchicago.edu/doi/full/10.1086/655394), in the September 1, 2010 issue of The Journal of Infectious Diseases.

25 Aug 2010

AGA Medical Holdings files patent infringement lawsuit against Gore

AGA Medical Holdings, Inc. today announced that it has filed a patent infringement lawsuit against W.L. Gore & Associates (Gore). AGA Medical is alleging that Gore is infringing AGA Medical's U.S. Patent No. 5,994,738 which covers certain transcatheter occlusion products for the treatment of structural heart defects.

25 Aug 2010

Simulations Plus launches Version 7.0 of GastroPlus software for pharmaceutical industry

Simulations Plus, Inc.,a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of Version 7.0 of GastroPlus, the industry's gold standard software for the simulation of drug absorption, pharmacokinetics, and pharmacodynamics.

25 Aug 2010

Healthcare Trust of America to acquire 228,870 square foot West Penn Allegheny Building for $41.34M

Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the execution of an agreement to acquire an office building in Pittsburgh, Pennsylvania (the "West Penn Allegheny Building") for approximately $41,340,000. The closing of the acquisition is subject to the satisfaction of a number of conditions.

25 Aug 2010

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor

Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.

25 Aug 2010

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Agilent Technologies Inc.today introduced the SureSelect Human All Exon v2 Target Enrichment kit, which was developed in close collaboration with the Broad Institute of MIT and Harvard. The kit, the 15th SureSelect product in Agilent's portfolio, is a single tube assay that allows researchers to streamline experiments by sequencing the expressed genome while discarding regions not of interest.

25 Aug 2010

ITelagen finds place on 2010 Inc. 5000 list of fastest-growing US companies

ITelagen, Inc., a leading provider of healthcare IT and medical billing solutions, today announced that the company was named to the prestigious 2010 Inc. 5000 list, a compendium of the most entrepreneurial and fastest growing companies in America.

25 Aug 2010

Rock Sake traditional white spirits are gluten and sulfite free

The movement toward high quality, all natural food and drink continues to gain momentum and Americans need a cocktail that fits in with their healthy lifestyle. Rock Sake is a line of ultra-premium, domestically produced sake that is a delicious and nutritious alternative to traditional white spirits. Per ounce, Rock Sake is half the calories of vodka, rum and other white spirits and is gluten and sulfite free.

25 Aug 2010

Fewer N.C. physicians seeing Medicare patients; Hospitals try to cut Medicare readmissions

"The national health care reform law, which was was designed to provide insurance coverage and access to physicians to more Americans, has no provision to help a group already having difficulty finding doctors to treat them - senior citizens. According to a report from Cigna Government Services, which processes Medicare claims in North Carolina and 17 other states, more than 80 physicians in North Carolina have opted out of Medicare in the past year. That's in addition to the 100 physicians statewide who stopped seeing Medicare patients in 2008, the report states.

25 Aug 2010

OpenEye releases Docking TK software to develop new docking tools

OpenEye Scientific Software, Inc. the developer of innovative molecular modeling and cheminformatics solutions for drug discovery, announces the first release of the Docking TK as part of the OpenEye Toolkit v1.7.4 release.

25 Aug 2010

Researchers identify specific gene responsible for Kuf's disease

A North Carolina State University researcher has helped to locate and identify a gene responsible for a fatal neurodegenerative disease that affects American Staffordshire terriers. This same gene may be responsible for a similar rare, fatal disease in humans. Its discovery will lead to improved screening and diagnosis of the disease in dogs and is the first step in working toward a cure for both canines and humans.

25 Aug 2010

CMC Biologics completes new, disposable manufacturing facility at Seattle

CMC Biologics, a Contract Manufacturing Organization with manufacturing sites in Europe and the USA, today announced the completion of a new state-of-the-art disposable manufacturing facility at its Seattle, WA site. The addition comes as part of a staged major expansion plan, which will add significant production capacity to its existing facility to accommodate a growing demand for cGMP manufacture of biopharmaceuticals.

25 Aug 2010

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.

25 Aug 2010

Fluoridation exposure during childhood prevents adult tooth loss

Children drinking water with added fluoride helps dental health in adulthood decades later, a new study finds.

25 Aug 2010

New TRIM5α-based treatments can knock out HIV in humans: Research

Using a $225,000 microscope, researchers have identified the key components of a protein called TRIM5α that destroys HIV in rhesus monkeys.The finding could lead to new TRIM5α-based treatments that would knock out HIV in humans, said senior researcher Edward M. Campbell, PhD, of Loyola University Health System.

25 Aug 2010

Study finds measurable immunity to pandemic H1N1 virus in Norway population

By autumn 2009, almost half of the population of Norway had been vaccinated against the pandemic influenza A (H1N1) virus. Many had also been infected by the virus during the summer and autumn outbreaks. The majority of those who were vaccinated or were infected are expected to have developed immunity to the virus.

25 Aug 2010

Health law continues to be embroiled in politics, though toned down

In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.

25 Aug 2010

Sheryl Crow Imaging Center opens in Los Angeles

Breast cancer survivor Sheryl Crow and the Pink Lotus Breast Center today announced the grand opening of the Sheryl Crow Imaging Center, a state of the art breast imaging center featuring the latest advancements in digital screening and diagnostic imaging technologies.

25 Aug 2010

FDA recalls eggs in multi-state Salmonella outbreak

The number of eggs being recalled in a multi-state Salmonella outbreak is growing.

25 Aug 2010

Two diabetes medications increase risk of heart attack, failure: Study

In contrast to previous reports, the risks of the composite endpoint of heart attack, heart failure, both, or death were the same about 4 percent for patients taking the diabetes drugs rosiglitazone or pioglitazone, according to a study published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

25 Aug 2010